166 related articles for article (PubMed ID: 24649870)
1. Interleukin-1 receptor antagonist modulates inflammation and scarring after ligament injury.
Chamberlain CS; Leiferman EM; Frisch KE; Duenwald-Kuehl SE; Brickson SL; Murphy WL; Baer GS; Vanderby R
Connect Tissue Res; 2014 Jun; 55(3):177-86. PubMed ID: 24649870
[TBL] [Abstract][Full Text] [Related]
2. Interleukin expression after injury and the effects of interleukin-1 receptor antagonist.
Chamberlain CS; Leiferman EM; Frisch KE; Brickson SL; Murphy WL; Baer GS; Vanderby R
PLoS One; 2013; 8(8):e71631. PubMed ID: 23936523
[TBL] [Abstract][Full Text] [Related]
3. Microparticles Locally Deliver Active Interleukin-1 Receptor Antagonist In Vivo.
Clements AEB; Groves ER; Chamberlain CS; Vanderby R; Murphy WL
Adv Healthc Mater; 2018 Aug; 7(16):e1800263. PubMed ID: 29974661
[TBL] [Abstract][Full Text] [Related]
4. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study.
Galea J; Ogungbenro K; Hulme S; Patel H; Scarth S; Hoadley M; Illingworth K; McMahon CJ; Tzerakis N; King AT; Vail A; Hopkins SJ; Rothwell N; Tyrrell P
J Neurosurg; 2018 Feb; 128(2):515-523. PubMed ID: 28298024
[TBL] [Abstract][Full Text] [Related]
5. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.
Yamada J; Dana MR; Sotozono C; Kinoshita S
Exp Eye Res; 2003 Feb; 76(2):161-7. PubMed ID: 12565803
[TBL] [Abstract][Full Text] [Related]
6. IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes.
Wang F; Liu J; Chen X; Zheng X; Qu N; Zhang B; Xia C
Arthritis Res Ther; 2019 Jul; 21(1):171. PubMed ID: 31291980
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat.
Cartmell T; Luheshi GN; Hopkins SJ; Rothwell NJ; Poole S
J Physiol; 2001 Feb; 531(Pt 1):171-80. PubMed ID: 11179401
[TBL] [Abstract][Full Text] [Related]
8. The influence of interleukin-4 on ligament healing.
Chamberlain CS; Leiferman EM; Frisch KE; Wang S; Yang X; Brickson SL; Vanderby R
Wound Repair Regen; 2011; 19(3):426-35. PubMed ID: 21518087
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist ameliorates the pain hypersensitivity, spinal inflammation and oxidative stress induced by systemic lipopolysaccharide in neonatal rats.
Hsieh CT; Lee YJ; Lee JW; Lu S; Tucci MA; Dai X; Ojeda NB; Lee HJ; Fan LW; Tien LT
Neurochem Int; 2020 May; 135():104686. PubMed ID: 31987865
[TBL] [Abstract][Full Text] [Related]
10. IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation.
Rider P; Carmi Y; Yossef R; Guttman O; Eini H; Azam T; Dinarello CA; Lewis EC
J Immunol; 2015 Aug; 195(4):1705-12. PubMed ID: 26157171
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo.
Klueh U; Antar O; Qiao Y; Kreutzer DL
J Diabetes Sci Technol; 2013 Nov; 7(6):1538-46. PubMed ID: 24351180
[TBL] [Abstract][Full Text] [Related]
12. Primed Mesenchymal Stem Cells Alter and Improve Rat Medial Collateral Ligament Healing.
Saether EE; Chamberlain CS; Aktas E; Leiferman EM; Brickson SL; Vanderby R
Stem Cell Rev Rep; 2016 Feb; 12(1):42-53. PubMed ID: 26530282
[TBL] [Abstract][Full Text] [Related]
13. IL-1 Receptor Antagonist Inhibits Early Granulation Formation.
Nicolli EA; Ghosh A; Haft S; Frank R; Saunders CJ; Cohen N; Mirza N
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):284-9. PubMed ID: 26522467
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury.
Qian W; Zhao C; Li D; Dai R
Arch Cardiovasc Dis; 2018 Oct; 111(10):545-554. PubMed ID: 29724623
[TBL] [Abstract][Full Text] [Related]
15. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.
McCall RD; Haskill S; Zimmermann EM; Lund PK; Thompson RC; Sartor RB
Gastroenterology; 1994 Apr; 106(4):960-72. PubMed ID: 8144001
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 receptor antagonist enhances the therapeutic efficacy of a low dose of rhBMP-2 in a weight-bearing rat femoral defect model.
Lackington WA; Gehweiler D; Zhao E; Zderic I; Nehrbass D; Zeiter S; González-Vázquez A; O'Brien FJ; Stoddart MJ; Thompson K
Acta Biomater; 2022 Sep; 149():189-197. PubMed ID: 35840106
[TBL] [Abstract][Full Text] [Related]
17. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.
Ulich TR; Guo K; Yin S; del Castillo J; Yi ES; Thompson RC; Eisenberg SP
Am J Pathol; 1992 Jul; 141(1):61-8. PubMed ID: 1385928
[TBL] [Abstract][Full Text] [Related]
19. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.
Mandrup-Poulsen T; Wogensen LD; Jensen M; Svensson P; Nilsson P; Emdal T; Mølvig J; Dinarello CA; Nerup J
Crit Care Med; 1995 Jan; 23(1):26-33. PubMed ID: 8001382
[TBL] [Abstract][Full Text] [Related]
20. Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection.
Greenhalgh AD; Galea J; Dénes A; Tyrrell PJ; Rothwell NJ
Br J Pharmacol; 2010 May; 160(1):153-9. PubMed ID: 20412072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
